DK1070083T3 - Krystallinske former af 1-S-[1alfa(2S*,3R*), 9alfa]-6, 10-dioxo-N- (2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9- [[(1 isoquinolyl)carbonyl]octahydro-6H-piridazino[1,2-a][1,2]diazepin-1-carboxamid - Google Patents

Krystallinske former af 1-S-[1alfa(2S*,3R*), 9alfa]-6, 10-dioxo-N- (2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9- [[(1 isoquinolyl)carbonyl]octahydro-6H-piridazino[1,2-a][1,2]diazepin-1-carboxamid

Info

Publication number
DK1070083T3
DK1070083T3 DK99911890T DK99911890T DK1070083T3 DK 1070083 T3 DK1070083 T3 DK 1070083T3 DK 99911890 T DK99911890 T DK 99911890T DK 99911890 T DK99911890 T DK 99911890T DK 1070083 T3 DK1070083 T3 DK 1070083T3
Authority
DK
Denmark
Prior art keywords
piridazino
9alpha
1alpha
diazepine
octahydro
Prior art date
Application number
DK99911890T
Other languages
Danish (da)
English (en)
Inventor
Jean-Yves Godard
Valerie Rognon
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1070083T3 publication Critical patent/DK1070083T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
DK99911890T 1998-04-08 1999-04-07 Krystallinske former af 1-S-[1alfa(2S*,3R*), 9alfa]-6, 10-dioxo-N- (2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9- [[(1 isoquinolyl)carbonyl]octahydro-6H-piridazino[1,2-a][1,2]diazepin-1-carboxamid DK1070083T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9804367A FR2777279B1 (fr) 1998-04-08 1998-04-08 Nouvelles formes cristallines du 1s-[1alpha(2s*,3r*), 9 alpha] 6,10-dioxo-n-(2-ethoxy-5-oxo-tetrahydro-3-furanyl) -9[[(1-isoquinolyl)carbonyl]amino]octohydro-6h-pyridazino [1,2-a][1,2]diazepine-1-carboxamide

Publications (1)

Publication Number Publication Date
DK1070083T3 true DK1070083T3 (da) 2006-05-15

Family

ID=9524993

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99911890T DK1070083T3 (da) 1998-04-08 1999-04-07 Krystallinske former af 1-S-[1alfa(2S*,3R*), 9alfa]-6, 10-dioxo-N- (2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9- [[(1 isoquinolyl)carbonyl]octahydro-6H-piridazino[1,2-a][1,2]diazepin-1-carboxamid

Country Status (38)

Country Link
US (2) US6544977B1 (cs)
EP (1) EP1070083B1 (cs)
JP (1) JP2002511485A (cs)
KR (1) KR100582981B1 (cs)
CN (1) CN1202123C (cs)
AP (1) AP1734A (cs)
AR (1) AR018328A1 (cs)
AT (1) ATE315044T1 (cs)
AU (1) AU758042B2 (cs)
BG (1) BG64736B1 (cs)
BR (1) BR9909549A (cs)
CA (1) CA2325629C (cs)
CU (1) CU23055A3 (cs)
CZ (1) CZ299744B6 (cs)
DE (1) DE69929315T2 (cs)
DK (1) DK1070083T3 (cs)
EA (1) EA002761B1 (cs)
EE (1) EE04467B1 (cs)
ES (1) ES2253880T3 (cs)
FR (1) FR2777279B1 (cs)
GE (1) GEP20032974B (cs)
HK (1) HK1038575B (cs)
HR (1) HRP20000665B1 (cs)
HU (1) HU227561B1 (cs)
ID (1) ID26290A (cs)
IL (2) IL138818A (cs)
ME (1) ME01627B (cs)
NO (1) NO327995B1 (cs)
NZ (1) NZ507199A (cs)
PL (1) PL197016B1 (cs)
RS (1) RS49916B (cs)
SI (1) SI1070083T1 (cs)
SK (1) SK286267B6 (cs)
TR (1) TR200002914T2 (cs)
TW (1) TW522152B (cs)
UA (1) UA71563C2 (cs)
WO (1) WO1999052935A1 (cs)
ZA (1) ZA200005438B (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2044025T3 (pl) * 2006-06-30 2013-02-28 Novartis Ag Pochodne chinolinonu i ich kompozycje farmaceutyczne
AU2014277867B2 (en) * 2007-12-04 2016-11-03 Arbutus Biopharma Corporation Targeting lipids

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204261B1 (en) * 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
US5552400A (en) * 1994-06-08 1996-09-03 Sterling Winthrop Inc. Fused-bicyclic lactams as interleukin-1β converting enzyme inhibitors

Also Published As

Publication number Publication date
CA2325629A1 (fr) 1999-10-21
EP1070083A1 (fr) 2001-01-24
NZ507199A (en) 2002-12-20
JP2002511485A (ja) 2002-04-16
IL138818A (en) 2008-11-26
EE200000586A (et) 2002-02-15
NO20005060D0 (no) 2000-10-06
HUP0101586A3 (en) 2002-11-28
YU60800A (sh) 2002-11-15
TR200002914T2 (tr) 2001-02-21
SI1070083T1 (sl) 2006-04-30
SK286267B6 (sk) 2008-06-06
ME01627B (me) 2008-09-29
CZ20003678A3 (cs) 2001-02-14
ID26290A (id) 2000-12-14
PL197016B1 (pl) 2008-02-29
TW522152B (en) 2003-03-01
WO1999052935A1 (fr) 1999-10-21
US20030171365A1 (en) 2003-09-11
US6544977B1 (en) 2003-04-08
AR018328A1 (es) 2001-11-14
HUP0101586A2 (hu) 2001-11-28
SK14882000A3 (sk) 2001-04-09
HRP20000665A2 (en) 2001-08-31
NO20005060L (no) 2000-10-06
EE04467B1 (et) 2005-04-15
KR100582981B1 (ko) 2006-05-24
ATE315044T1 (de) 2006-02-15
UA71563C2 (uk) 2004-12-15
HK1038575A1 (en) 2002-03-22
GEP20032974B (en) 2003-05-27
FR2777279B1 (fr) 2004-08-13
BG104829A (en) 2001-05-31
HU227561B1 (en) 2011-08-29
IL168047A (en) 2011-10-31
DE69929315T2 (de) 2006-08-17
AU758042B2 (en) 2003-03-13
ES2253880T3 (es) 2006-06-01
US6946459B2 (en) 2005-09-20
NO327995B1 (no) 2009-11-02
BR9909549A (pt) 2000-12-12
KR20010034759A (ko) 2001-04-25
CN1202123C (zh) 2005-05-18
AP2000001939A0 (en) 2000-12-31
CU23055A3 (es) 2005-06-24
EP1070083B1 (fr) 2006-01-04
HK1038575B (zh) 2006-01-06
PL343350A1 (en) 2001-08-13
CN1305491A (zh) 2001-07-25
HRP20000665B1 (en) 2008-01-31
CZ299744B6 (cs) 2008-11-12
RS49916B (sr) 2008-09-29
EA200001047A1 (ru) 2001-04-23
AU3041699A (en) 1999-11-01
CA2325629C (fr) 2013-01-22
BG64736B1 (bg) 2006-01-31
AP1734A (en) 2007-03-22
ZA200005438B (en) 2002-01-07
DE69929315D1 (de) 2006-03-30
FR2777279A1 (fr) 1999-10-15
EA002761B1 (ru) 2002-08-29

Similar Documents

Publication Publication Date Title
ID23238A (id) Platform dudukan berputar stabilitas tinggi
ID28632A (id) Proses untuk memproduksi olefin-olefin
DE69923308D1 (de) Stuhlstruktur
IT1294332B1 (it) Seggiolone regolabile
DE69931855D1 (de) Hautpräparat
IT1282627B1 (it) Procedimento per la preparazione di perfluoropoliossialchileni perossidici
ID22131A (id) Turunan-turunan 1,2,3,4-tetrahidro-benzofuran [3,2-c] piridin
KR970704449A (ko) 경피 흡수 제제(Percutaneously Absorbable Preparation)
DE59912915D1 (de) Herstellung von 4,4'-Diketo-carotinoiden
ID20093A (id) Metode untuk memproduksi polibutilena tereptalat
DK1070083T3 (da) Krystallinske former af 1-S-[1alfa(2S*,3R*), 9alfa]-6, 10-dioxo-N- (2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9- [[(1 isoquinolyl)carbonyl]octahydro-6H-piridazino[1,2-a][1,2]diazepin-1-carboxamid
FI962609L (fi) Menetelmä ksylitolin valmistamiseksi
DE69904953D1 (de) Bipolarer separator
IS5877A (is) Ný efnablanda
ITMI992457A0 (it) Procedimento per la preparazione di (s)-n-terbutil-1,2,3,4-tetraidrois ochinolin-3-carbossiammide
FR2784878B1 (fr) Accoudoir
IT1308677B1 (it) Procedimento per produrre 2,2,6,6-tetrametil-4-piperidone
ITMI970682A0 (it) Procedimento per la preparazione di (s)-n-terbutil-1,2,3,4- tetraidroisochinolin-3- carbossiammide
EE03762B1 (et) Protsess NMDA antagonistide valmistamiseks
IT246475Y1 (it) Carrozzina per bambini
ITMI950539A0 (it) Procedimento per la preparazione di diidropiridine
IT1299794B1 (it) Sedia smontabile
IT1302545B1 (it) Sedia smontabile
ITMI942439A0 (it) 1,3,2-benzossiazafosfolidine sostituite e procedimento per la loro preparazione
ITMI942438A0 (it) 1,3,2-benzoossiazafosfolidine sostituite e procedimento per la loro preparazione